Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
Market Capitalization: 135.31 M
The data is delayed by 15 minutes.
Description: Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors. Its lead product candidate includes intravenous CR845, which has completed Phase II clinical trials for the treatment acute postoperative pain in adult patients. The company is also developing Oral CR845 that has completed Phase I clinical trial for the treatment of moderate-to-severe acute and chronic pain; and CR701, which is in preclinical trial for treating neuropathic and inflammatory pain. Cara Therapeutics, Inc. was founded in 2004 and is based in Shelton, Connecticut.
|Shares Outstanding||27.28 M||EPS||-2.52||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||-49.06%||Sales Growth - Q/Q||-46.5%||P/E||-6.79|
|P/E To EPS Growth||P/S||38.79||P/BV||2.85||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-36.88%||ROE||-40.17%||ROI|
|Current Ratio||14.31||Quick Ratio||Long Term Debt/Equity||Debt Ratio||0.07|
|Gross Margin||Operating Margin||-555.3%||Net Profit Margin||-546.19%||Dividend Payout Ratio|
|Cash From Financing Activities||10 K||Cash From Investing Activities||-10 K||Cash From Operating Activities||-5.24 M||Gross Profit|
|Net Profit||-4.69 M||Operating Profit||-4.72 M||Total Assets||51.65 M||Total Current Assets||49.06 M|
|Total Current Liabilities||3.43 M||Total Debt||800 K||Total Liabilities||4.23 M||Total Revenue||490 K|
|High 52 week||23.95||Low 52 week||11.6||Last close||15.25||Last change||0.33%|
|RSI||67.7||Average true range||0.88||Beta||1.58||Volume||1.26 M|
|Simple moving average 20 days||6.82%||Simple moving average 50 days||-7.24%||Simple moving average 200 days||-11.66%|
|Performance Week||-2.68%||Performance Month||8.54%||Performance Quart||-21.39%||Performance Half||-29.4%|
|Performance Year||23.78%||Performance Year-to-date||17.31%||Volatility daily||3.73%||Volatility weekly||8.33%|
|Volatility monthly||17.07%||Volatility yearly||59.14%||Relative Volume||252.99%||Average Volume||603.3 K|
|New High||New Low|
2019-03-13 21:50:08 | Edited Transcript of CARA earnings conference call or presentation 12-Mar-19 8:30pm GMT
2019-03-13 13:01:47 | Here's Why Cara Therapeutics Stock Rose as Much as 13.9% Today
2019-03-13 12:15:00 | These Four Marijuana Stocks Are Raising Eyebrows on Wednesday
2019-03-13 00:19:42 | Cara Therapeutics Inc CARA Q4 2018 Earnings Conference Call Transcript
2019-03-12 17:35:01 | Stocks making the biggest moves after hours: Switch, Clearwater Paper and more
2019-03-12 17:20:09 | Cara Therapeutics CARA Reports Q4 Loss, Tops Revenue Estimates
2019-03-12 16:27:34 | Cara: 4Q Earnings Snapshot
2019-03-12 16:01:00 | Cara Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
2019-03-12 10:00:00 | Top Cannabis Plays-THC Therapeutics, Inc
2019-03-07 08:57:01 | Athersys ATHX Q4 Earnings: What's in Store for the Stock?
2019-03-07 08:51:01 | Is a Beat in Store for Catabasis CATB This Earnings Season?
2019-03-04 06:41:11 | Can Segmental Growth Aid Cooper Companies' COO Q1 Earnings?
2019-03-03 10:15:00 | Better Buy: Cara Therapeutics vs. Scotts Miracle-Gro Company
2019-02-22 16:43:09 | What's in Store for Vericel VCEL This Earnings Season?
2019-02-15 08:20:00 | Consolidated Research: 2019 Summary Expectations for Tenaris S.A, Rapid7, Halozyme Therapeutics, Cara Therapeutics, EnPro Industries, and K12 — Fundamental Analysis, Key Performance Indications
2019-02-13 13:47:53 | Should You Buy, Sell, Or Hold These 7 Medical Cannabis Stocks?
2019-02-12 09:00:00 | Biotech Plays in the News You Should Know
2019-02-11 13:56:07 | Here's Why Cara Therapeutics Stock Rose 17.3% in January
2019-02-08 12:10:00 | These 4 Marijuana Stocks Are Looking Strong
2019-02-06 14:45:00 | Watch These Marijuana Stocks Hit The Ground Running On Wednesday 2/6/19
2019-02-05 08:00:00 | Biotech Stocks to Watch
2019-02-02 13:11:11 | New Cannabis Products Which Could Disrupt the Industry in 2019
2019-01-31 16:09:56 | Better Buy: GW Pharmaceuticals vs. Cara Therapeutics
2019-01-31 08:30:00 | Biotechs Investors Are Flocking To
2019-01-30 15:00:02 | Analyzing CARA, INSY, and GWPH’s Earnings Trends
2019-01-30 13:30:02 | Cannabis Stocks: CARA, INSY, and GWPH’s Revenue Trajectory
2019-01-30 11:58:56 | CARA, INSY, and GWPH: Analysts’ Recommendations in January
2019-01-29 08:30:00 | Cannabis and Biotech Stocks that Could Explode
2019-01-28 08:00:00 | Biotech Stocks to Watch this Week
2019-01-24 12:08:40 | Is Cara Therapeutics a Buy?
2019-01-24 08:10:00 | Consolidated Research: 2019 Summary Expectations for First Data, IDEXX Laboratories, CMS Energy, Worthington Industries, Triumph Group, and Cara Therapeutics — Fundamental Analysis, Key Performance Indications
2019-01-23 13:30:02 | Cara Therapeutics: Earnings Trends and Recent Developments
2019-01-23 12:00:02 | Cara Therapeutics: A Financial Overview in January
2019-01-23 10:26:26 | Cara Therapeutics Has Risen ~18% in January
2019-01-21 10:53:42 | Top Marijuana Stocks on the NASDAQ
2019-01-18 09:36:42 | With Trial Results Due, This Could Be a Breakout Year for Cara Stock
2019-01-16 11:01:27 | These Cannabis Stocks Are Soaring in January
2019-01-11 16:55:02 | How Is INSYS Therapeutics Financially Positioned in January?
2019-01-10 21:19:00 | Here's Why Cara Therapeutics Fell 28.5% in December
2019-01-10 16:20:01 | A Look into GW Pharmaceuticals’ Revenue Trends
2019-01-04 17:11:31 | Which Biopharma Stocks Are Looking To Score Big In Cannabis Medicine?
2019-01-03 17:43:10 | Cara CARA Up on IDMC's Recommendation to Continue Trial
2019-01-02 07:00:00 | Cara Therapeutics Announces No Modifications in Trial Size After Completion of Interim Statistical Assessment For KALM-1 Phase 3 Trial Of KORSUVA™ Injection in Hemodialysis Patients with Pruritus
2018-12-23 03:38:30 | Is Casa Therapeutics Inc CARA Going to Burn These Hedge Funds?
2018-12-21 10:30:02 | What’s Auxly Cannabis’ MidStream Strategy in 2018?
2018-12-19 12:20:00 | Cara Therapeutics Stock Could Outperform in 2019
2018-12-18 08:45:00 | 4 Marijuana Stocks To Watch On Tuesday 12/18/2018